Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Regor Pharmaceuticals Inc.
Regor Pharmaceuticals Inc.
Seagen Inc.
Eli Lilly and Company
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
Genentech, Inc.
National Cancer Institute (NCI)
Eli Lilly and Company
OncoC4, Inc.
Kortuc, Inc.
KaliVir Immunotherapeutics
Arcus Biosciences, Inc.
Radiopharm Theranostics, Ltd
Sotio Biotech Inc.